Kadmon Holdings, Inc.
KDMNDelisted Nov 9, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557142
Kadmon Holdings, Inc. was delisted on Nov 9, 2021; its insiders filed their last Form 4 on Nov 9, 2021; 169 institutions reported holding it in 13F filings for Q3 2021, worth $1.37B in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:30 PM ET
Revenue flow, FY2020
Where the revenue went in FY2020, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2020: $108.9M (1314.1% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2021 | Mar 5, 2020 | Mar 7, 2019 | Mar 6, 2018 | Mar 22, 2017 |
| Revenue | $8.29M | $5.09M | $1.40M | $12.3M | $26.1M |
| Cost of revenue | – | – | $682.0K | – | – |
| Gross profit | $6.29M | $3.81M | $714.0K | $9.28M | $22.2M |
| Operating expenses | $108.6M | $92.9M | $86.6M | $77.8M | $137.6M |
| Research and development | $65.4M | $56.5M | $49.0M | $40.8M | $35.8M |
| Selling, general and administrative | $43.2M | $36.4M | $37.6M | $37.1M | $105.9M |
| Operating income | -$102.3M | -$89.1M | -$85.9M | -$68.6M | -$115.4M |
| Interest expense | $21.0K | $3.38M | $4.62M | $5.96M | $72.6M |
| Income tax | -$182.0K | $46.0K | -$524.0K | -$121.0K | $342.0K |
| Net income | -$108.9M | -$61.4M | -$54.3M | -$79.8M | -$208.8M |
| Margins and growth | |||||
| Gross margin | 75.9% | 74.7% | 51.1% | 75.7% | 85.1% |
| Operating margin | -1234.1% | -1748.4% | -6153.0% | -559.0% | -442.9% |
| Net margin | -1314.1% | -1204.5% | -3886.2% | -650.5% | -801.2% |
| Revenue growth, year over year | +62.7% | +265.0% | −88.6% | −52.9% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2021 | Mar 5, 2020 | Mar 7, 2019 | Mar 6, 2018 | Mar 22, 2017 |
| Cash and equivalents | $74.4M | $139.6M | $94.7M | $67.5M | $36.1M |
| Short-term investments | $49.4M | – | – | – | – |
| Accounts receivable | $695.0K | $954.0K | $1.69M | $325.0K | $655.0K |
| Inventory | $102.0K | $640.0K | $925.0K | $201.0K | $1.95M |
| Total current assets | $137.3M | $184.6M | $98.9M | $70.0M | $40.3M |
| Property, plant and equipment | $1.29M | $2.44M | $3.65M | $4.29M | $5.43M |
| Goodwill | $3.58M | $3.58M | $3.58M | $3.58M | $3.58M |
| Total assets | $162.7M | $214.8M | $144.7M | $83.6M | $62.6M |
| Accounts payable | $10.9M | $9.04M | $9.99M | $8.01M | $6.30M |
| Short-term debt | – | – | – | $33.7M | $1.90M |
| Total current liabilities | $29.5M | $28.7M | $24.0M | $56.6M | $24.7M |
| Long-term debt | – | – | $27.5M | $33.7M | $28.7M |
| Total liabilities | $46.7M | $49.1M | $56.3M | $81.8M | $87.7M |
| Shareholders' equity | $116.0M | $165.7M | $88.4M | $1.76M | -$25.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2021 | Mar 5, 2020 | Mar 7, 2019 | Mar 6, 2018 | Mar 22, 2017 |
| Operating cash flow | -$87.5M | -$80.1M | -$71.2M | -$64.1M | – |
| Capital expenditures | $443.0K | $515.0K | $864.0K | $479.0K | $539.0K |
| Free cash flow | -$88.0M | -$80.6M | -$72.1M | -$64.6M | – |
| Depreciation and amortization | – | $1.78M | $1.53M | $1.82M | $2.28M |
| Stock-based compensation | $9.36M | $7.21M | $10.4M | $12.4M | $47.2M |
| Investing cash flow | -$30.6M | $21.5M | -$864.0K | -$479.0K | – |
| Financing cash flow | $52.9M | $103.4M | $99.3M | $96.0M | – |
| Net change in cash | – | – | – | $31.4M | $14.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 113.0% | 141.5% | 744.3% | 100.7% | 181.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 1, 2021 | 178.5M | +4.1% | SEC |
| Aug 2, 2021 | 172.4M | +0.7% | SEC |
| May 3, 2021 | 172.0M | +7.5% | SEC |
| Mar 1, 2021 | 171.8M | +7.5% | SEC |
| Nov 2, 2020 | 171.5M | +32.2% | SEC |
| Aug 3, 2020 | 171.1M | +32.0% | SEC |
| May 4, 2020 | 160.0M | +23.6% | SEC |
| Mar 2, 2020 | 159.8M | +25.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.